Literature DB >> 21491438

High throughput formulation screening for global aggregation behaviors of three monoclonal antibodies.

Yi Li1, Henryk Mach, Jeffrey T Blue.   

Abstract

Global aggregation behaviors of three distinct monoclonal antibodies were characterized by high throughput, multiassay analysis. First, extensive screening of formulations was performed using both incubation at elevated temperature and differential thermal scanning. In incubation studies, formulation conditions representing native favored, native favored but with particulate formation, unfolding with slow aggregation, and fast aggregation with or without phase separation were mapped across a wide range of pH and ionic strength. The sample types or aggregation kinetic scenarios were classified based on fluorescence spectroscopy, light scattering, and micron particle count. Furthermore, apparent melting point was determined for each formulation condition by differential thermal scanning. The global aggregation behaviors and their apparent melting points together highlight the common underlying aggregation pathways and kinetics for the three antibodies. Overall, incorporating multistage aggregation mechanisms in multivariate data analysis provides valuable insights to what and how high throughput techniques can be implemented. Understanding global aggregation behaviors is a key element toward development of rational screening approach.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21491438     DOI: 10.1002/jps.22450

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  High Throughput Differential Scanning Fluorimetry (DSF) Formulation Screening with Complementary Dyes to Assess Protein Unfolding and Aggregation in Presence of Surfactants.

Authors:  Sean M McClure; Patrick L Ahl; Jeffrey T Blue
Journal:  Pharm Res       Date:  2018-03-05       Impact factor: 4.200

2.  Modification of the kinetic stability of immunoglobulin G by solvent additives.

Authors:  Jonas V Schaefer; Erik Sedlák; Florian Kast; Michal Nemergut; Andreas Plückthun
Journal:  MAbs       Date:  2018-04-25       Impact factor: 5.857

Review 3.  Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization.

Authors:  Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2013-06-06       Impact factor: 6.098

Review 4.  Early implementation of QbD in biopharmaceutical development: a practical example.

Authors:  Jesús Zurdo; Andreas Arnell; Olga Obrezanova; Noel Smith; Ramón Gómez de la Cuesta; Thomas R A Gallagher; Rebecca Michael; Yvette Stallwood; Caroline Ekblad; Lars Abrahmsén; Ingmarie Höidén-Guthenberg
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

Review 5.  Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans.

Authors:  Victoria S Jasion; Bruce P Burnett
Journal:  Nutr J       Date:  2015-03-07       Impact factor: 3.271

6.  The effect of arginine glutamate on the stability of monoclonal antibodies in solution.

Authors:  Priscilla Kheddo; Malgorzata Tracka; Jonathan Armer; Rebecca J Dearman; Shahid Uddin; Christopher F van der Walle; Alexander P Golovanov
Journal:  Int J Pharm       Date:  2014-06-30       Impact factor: 5.875

7.  Evaluation of Crystal Zenith Microtiter Plates for High-Throughput Formulation Screening.

Authors:  J Alaina Floyd; Jeremy M Shaver; Alison J Gillespie; Unjy Park; Richard S Rogers; Nancy S Nightlinger; Yuko Ogata; Jeffrey J James; Bruce A Kerwin
Journal:  J Pharm Sci       Date:  2019-10-25       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.